Aug 01, 2017 11:30 am UTC| Business
-- Primary endpoint is the reduction of liver fat, assessed by MRI-PDFF, at 12 weeks -- -- Company expects to report top-line results by year-end -- CONSHOHOCKEN, Pa., Aug. 01, 2017 -- Madrigal Pharmaceuticals, Inc....
Gran Colombia Gold Completes US$3.6 Million Reduction of Its 2020 Debentures in July 2017
Aug 01, 2017 11:30 am UTC| Business
TORONTO, Aug. 01, 2017 -- Gran Colombia Gold Corp. (TSX:GCM) announced today that its strategy to aggressively reduce its debt resulted in a US$3.6 million decrease in its Senior Secured Convertible Debentures due 2020...
Aug 01, 2017 11:30 am UTC| Business
IRVINE, Calif., Aug. 01, 2017 -- Identillect Technologies Corp. (the "Company" or "Identillect") (TSX-V:ID) (OTCQB:IDTLF) (Frankfurt:8ID) announced today that STAT MedCare Solutions, a leader in medical and behavioral...
CDK Global Reports Fiscal 2017 Results; Provides Fiscal 2018 Guidance
Aug 01, 2017 11:30 am UTC| Business
Fiscal Year Revenues Rise 5%, 6% on a Constant Currency Basis GAAP Earnings per Share Rise 32%, Adjusted Earnings per Share Rise 40% Guiding to Fiscal 2018 Net Earnings Attributable to CDK Margin of 14% - 15%,...
Intellia Therapeutics Announces Second Quarter 2017 Financial Results
Aug 01, 2017 11:30 am UTC| Business
In non-human primates, demonstrated robust green fluorescent protein expression throughout the liver 24 hours following a single, systemically delivered, intravenous dose, using our proprietary lipid nanoparticle delivery...
Zynerba Pharmaceuticals Reports Second Quarter 2017 Financial Results and Operational Highlights
Aug 01, 2017 11:30 am UTC| Business
DEVON, Pa., Aug. 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
KemPharm, Inc. to Report Second Quarter 2017 Results
Aug 01, 2017 11:30 am UTC| Business
Conference Call and Live Audio Webcast with Slide Presentation Scheduled forAugust 10, 2017, 4:30 p.m. ET CORALVILLE, Iowa, Aug. 01, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical...